Smoking, drinking, and depression: comorbidity in head and neck cancer patients undergoing radiotherapy
Author(s) -
McCarter Kristen,
Baker Amanda L.,
Britton Benjamin,
Wolfenden Luke,
Wratten Chris,
Bauer Judith,
Halpin Sean A.,
Carter Gregory,
Beck Alison K.,
Leigh Lucy,
Oldmeadow Christopher
Publication year - 2018
Publication title -
cancer medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.403
H-Index - 53
ISSN - 2045-7634
DOI - 10.1002/cam4.1497
Subject(s) - medicine , comorbidity , depression (economics) , radiation therapy , head and neck cancer , randomized controlled trial , alcohol consumption , psychological intervention , physical therapy , psychiatry , alcohol , biochemistry , chemistry , economics , macroeconomics
We aimed to determine the prevalence and co‐occurrence of tobacco smoking, alcohol consumption, and depressive symptoms among a sample of head and neck cancer ( HNC ) patients undergoing radiotherapy. A total of 307 HNC patients participated in a multi‐site stepped‐wedge randomized controlled trial ( RCT ) evaluating the effectiveness of a dietitian‐delivered health behavior intervention in patients with HNC undergoing radiotherapy. During week one of radiotherapy patients completed measures of smoking, alcohol consumption, and level of depression. Approximately one‐fifth (21%) of patients had two or more co‐occurring problems: current smoking, hazardous alcohol use, and/or likely presence of a major depressive episode ( MDE ). Approximately one‐third (34%) of the sample were current smokers, one‐third (31%) were drinking hazardously and almost one‐fifth (19%) had likely cases of depression. Comorbidity of smoking, hazardous alcohol use, and MDE is high in HNC patients, and interventions need to address this cluster of cancer risk factors.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom